97351 ⎘
Fusion polypeptide containing domain for protein-protein interaction containing SH2 domain
HIGH AFFINITY VARIANTS OF SH2 DOMAINS
#2RNA ENGINEERED T CELLS FOR THE TREATMENT OF CANCER
#3PYK2-DERIVED PEPTIDES FOR INHIBITING INVADOPODIA-MEDIATED CANCER METASTASIS
#4IMMUNE CELLS OVEREXPRESSING CELL SIGNALING REGULATORY FACTOR INTRODUCED FROM OUTSIDE AND USE THEREOF
#5RECEPTOR
#6Multispecific antibodies
#7RNA engineered T cells for the treatment of cancer
#8REWIRING ABERRANT CANCER SIGNALING TO A THERAPEUTIC EFFECTOR RESPONSE WITH A SYNTHETIC TWO-COMPONENT SYSTEM
#9Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains
#10METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#11USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#12Multispecific antibodies
#13Compositions, methods and kits for real-time nucleic acid analysis in live cells
#14RNA engineered T cells for the treatment of cancer
#15Vaccine for enveloped viruses
#16USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#17METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#18BIOSENSORS COMPRISING PROTEIN-BINDING DOMAINS AND FLUORESCENT PROTEINS
#19Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
#20Recombinant HIV-1 envelope proteins comprising stabilizing two-cysteine mini-domains in gp41
#21Methods of detecting transcription
#22MULTICOLOR BIOLUMINESCENT VISUALIZATION PROBE SET, OR SINGLE-MOLECULE-FORMAT MULTICOLOR BIOLUMINESCENT VISUALIZATION PROBE
#23Probes for analyzing interaction between proteins and method of analyzing interaction between proteins using the same